Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Rex Fang & Innovation Equity Premium Income ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Rex Fang & Innovation Equity Premium Income ETF vs Health Care Select Sector SPDR Fund — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $43.51 (market cap $746.48M), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 58.2× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 56 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

FEPIXLV
Market Cap
$746.48M$43.48B
Volume
334,33711,121,431
Sector
Income / Options Overlay—
52-Week High
$49.54$175.68
52-Week Low
$37.98$141.95
Typical Hold Time
56 Days100 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rex Fang & Innovation Equity Premium Income ETF

FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.18, down 0.94% with a bullish technical signal from moving averages. The ETF employs a covered call strategy on AI and mega-cap tech stocks, generating substantial weekly dividends averaging $0.20-0.21 per share. Technical indicators show support at $43 and resistance at $44, with RSI suggesting potential overbought conditions. Recent news highlights FEPI's 25% yield but notes underperformance versus peers in total returns.

The outlook remains income-focused with high yield appeal, though capped upside and concentrated tech exposure present risks. Elevated volatility in AI sectors could impact distributions, while competitive covered call ETFs offer alternatives. Investors should weigh income stability against total return potential and sector concentration risks in the current market environment.

Health Care Select Sector SPDR Fund

XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.

XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FEPI
25% Buy75% Sell
Avg holding period · 56 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

About Rex Fang & Innovation Equity Premium Income ETF

FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.

Read more on FEPI →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →